Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups.
作者信息
Jones Timothy D, Cheng Liang
机构信息
Department of Pathology, Norton Healthcare/CPA Lab, Louisville, KY, USA.
Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA.
出版信息
Eur Urol. 2021 Apr;79(4):489-491. doi: 10.1016/j.eururo.2021.01.005. Epub 2021 Jan 18.
PMID:33478775
Abstract
摘要
相似文献
1
Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups.膀胱肿瘤的组织学分级：联合使用1973年以及2004/2016年世界卫生组织系统可为建立预后风险组提供有价值的信息。
Eur Urol. 2021 Apr;79(4):489-491. doi: 10.1016/j.eururo.2021.01.005. Epub 2021 Jan 18.
2
Re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489-91.
Eur Urol. 2021 Jun;79(6):e172-e173. doi: 10.1016/j.eururo.2021.03.020. Epub 2021 Apr 8.
3
Reply to Alessia Cimadamore, Antonio Lopez-Beltran, Marina Scarpelli, and Rodolfo Montironi's Letter to the Editor re: Timothy D. Jones, Liang Cheng. Histologic Grading of Bladder Tumors: Using Both the 1973 and 2004/2016 World Health Organization Systems in Combination Provides Valuable Information for Establishing Prognostic Risk Groups. Eur Urol 2021;79:489-91: Towards Molecular Grading of Urothelial Tumors.回复阿莱西娅·奇马达莫尔、安东尼奥·洛佩斯 - 贝尔特兰、玛丽娜·斯卡佩利和罗多尔福·蒙蒂罗尼致编辑的信，信的主题为：蒂莫西·D·琼斯、梁成。膀胱肿瘤的组织学分级：联合使用1973年和2004/2016年世界卫生组织系统可为建立预后风险组提供有价值的信息。《欧洲泌尿外科杂志》2021年；79卷：489 - 491页：迈向尿路上皮肿瘤的分子分级
Eur Urol. 2021 Jun;79(6):e174-e175. doi: 10.1016/j.eururo.2021.03.027. Epub 2021 Apr 3.
4
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.1973 年和 2004/2016 年世界卫生组织分级分类系统在非肌肉浸润性膀胱癌中的预后性能和可重复性：欧洲泌尿外科学会非肌肉浸润性膀胱癌指南小组系统评价。
Eur Urol. 2017 Nov;72(5):801-813. doi: 10.1016/j.eururo.2017.04.015. Epub 2017 Apr 28.
5
Combining two grading systems: the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up.联合两种分级系统：1973 年和 2004 年世界卫生组织膀胱癌分类系统的临床有效性和观察者间变异性在英国队列中进行评估，前瞻性随访 15 年。
World J Urol. 2021 Feb;39(2):425-431. doi: 10.1007/s00345-020-03180-5. Epub 2020 Apr 7.
6
Reproducibility and Prognostic Performance of the 1973 and 2004 World Health Organization Classifications for Grade in Non-muscle-invasive Bladder Cancer: A Multicenter Study in 328 Bladder Tumors.1973 年和 2004 年世界卫生组织非肌肉浸润性膀胱癌分级分类的可重复性和预后性能：328 例膀胱肿瘤的多中心研究。
Clin Genitourin Cancer. 2018 Oct;16(5):e985-e992. doi: 10.1016/j.clgc.2018.05.002. Epub 2018 May 11.
7
Prognostic value and reproducibility of different microscopic characteristics in the WHO grading systems for pTa and pT1 urinary bladder urothelial carcinomas.WHO 分级系统中 pTa 和 pT1 尿路上皮膀胱癌不同微观特征的预后价值和可重复性。
Diagn Pathol. 2019 Aug 14;14(1):90. doi: 10.1186/s13000-019-0868-3.
8
Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.非肌肉浸润性膀胱癌患者的临床病理分析：2004 年 WHO 分类系统的预后价值和临床可靠性。
Jpn J Clin Oncol. 2013 Nov;43(11):1124-31. doi: 10.1093/jjco/hyt120. Epub 2013 Aug 26.
9
Histologic grading of urothelial carcinoma: a reappraisal.尿路上皮癌的组织学分级：再评价。
Hum Pathol. 2012 Dec;43(12):2097-108. doi: 10.1016/j.humpath.2012.01.008. Epub 2012 Apr 26.
10
The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading.病理学家的平均分级是恒定的，可使膀胱癌分级的预后价值个体化。
Eur Urol. 2010 Jun;57(6):1052-7. doi: 10.1016/j.eururo.2009.09.022. Epub 2009 Sep 11.
引用本文的文献
1
Uncovering the epidemiology of bladder cancer in the Arab world: A review of risk factors, molecular mechanisms, and clinical features.揭示阿拉伯世界膀胱癌的流行病学：风险因素、分子机制及临床特征综述
Asian J Urol. 2024 Jul;11(3):406-422. doi: 10.1016/j.ajur.2023.10.001. Epub 2023 Oct 31.
Zotero 插件